Eugene

[email protected]

LATEST

Charles River to Acquire Cell Therapy Provider HemaCare for $380 M
By

By
Charles River Laboratories, a contract research organization, has agreed to acquire HemaCare, a producer of human-derived cellular products for cell therapy, for approximately $380 million. The proposed purchase price equates…

Bausch Health Reaches $1.2-Billion Settlement in Securities Litigation
By

By
Bausch Health (formerly Valent Pharmaceuticals) has reached a $1.21-billion settlement in putative securities class action litigation initially brought against Valeant in a federal district court in New Jersey in October…

3M To Sell Drug Delivery Business to Altaris Capital Partners for $650 M
By

By
3M has agreed to sell substantially all of its drug-delivery business (except its transdermal drug-delivery component business) to an affiliate of the investment firm, Altaris Capital Partners, for $650 million.…

AbbVie and Scripps Research to Collaborate for Drug Development
By

By
AbbVie has formed a collaboration to develop new therapies for a range of diseases in therapeutic areas of oncology, immunology, neurology and fibrosis with Scripps Research, a non-profit biomedical research…

Roche Completes $4.3-Billion Acquisition of Spark Therapeutics
By

By
Roche has completed its $4.3-billion acquisition of Spark Therapeutics, a Philadelphia-based gene-therapy company. The completion follows the receipt of regulatory approval from all government authorities, including the US Federal Trade…

Global Pharma Briefs: News from Asia and the US
By

By
A roundup of developments and latest news from India (Aurobindo, Biocon), Japan (Kyowa Kirin), Singapore and South Korea (Ministry of Food and Drug Safety), United States (AstraZeneca, Recro Pharma, Horizon…

Sanofi Announces $2.2-Bn Cost-Savings Plan and Growth Strategy
By

By
Sanofi’s Chief Executive Officer (CEO) Paul Hudson and Executive Committee members have announced a cost-efficiency initiative of EUR 2 billion ($2.2 billion) and strategic growth plan with an emphasis on…

FDA Investigates Nitrosamine Impurities in Diabetes Drug Metformin
By

By
Janet Woodcock, Director of the Center for Drug Evaluation and Research of the US Food and Drug Administration provided an update on the FDA’s investigation of nitrosamine impurities in metformin,…

Janssen To Acquire Monoclonal Antibody from XBiotech for $750 M
By

By
Janssen Biotech, a Johnson & Johnson and Janssen company, has agreed to acquire all rights to the investigational compound, bermekimab from XBiotech, a developer of therapeutic antibodies, for a purchase…

Sanofi to Acquire Cancer Therapy Company Synthorx for $2.5 Billion
By

By
Sanofi has agreed to acquire Synthorx, a clinical-stage biotechnology company for cancer and autoimmune disorders, for $2.5 billion. The transaction was unanimously approved by Board of Directors of both Sanofi…